A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy.

A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy.

Complete clinical regressions of solid tumors in response to chemotherapy are difficult to explain by direct cytotoxicity alone, because of low growth fractions and obstacles to drug delivery. A plausible indirect mechanism that might reconcile this is the action of the immune system. A model for in...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Robertson-Tessi, M, El-Kareh, A, Goriely, A
Format:	Journal article
Sprog:	English
Udgivet:	Elsevier 2015

Lignende værker

A mathematical model of tumor-immune interactions.
af: Robertson-Tessi, M, et al.
Udgivet: (2012)

A mathematical model of tumor-immune interactions
af: Robertson-Tessi, M, et al.
Udgivet: (2010)

An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
af: Xinyuan Yuan, et al.
Udgivet: (2023-12-01)

The Goldilocks window of personalized chemotherapy: Getting the immune response just right
af: Park, D, et al.
Udgivet: (2019)

Dual-responsive nanosystem based on TGF-β blockade and immunogenic chemotherapy for effective chemoimmunotherapy
af: Xiaoxian Huang, et al.
Udgivet: (2022-12-01)

Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer
af: Marion Thibaudin, et al.
Udgivet: (2023-12-01)

A pH/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment
af: Leilei Wang, et al.
Udgivet: (2024-05-01)

Tumor immune dysfunction and exclusion evaluation and chemoimmunotherapy response prediction in lung adenocarcinoma using pathomic-based approach
af: Wei Nie, et al.
Udgivet: (2025-02-01)

Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy
af: Margaret R. Smith, et al.
Udgivet: (2023-03-01)

Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment
af: Jun Gu, et al.
Udgivet: (2022-08-01)

Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification
af: Manxiu Huai, et al.
Udgivet: (2024-05-01)

Efficient tumor synergistic chemoimmunotherapy by self-augmented ROS-responsive immunomodulatory polymeric nanodrug
af: Jinxiao Song, et al.
Udgivet: (2023-03-01)

Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma.
af: Katherine Dittrich, et al.
Udgivet: (2023-01-01)

Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations
af: Zhichao Liu, et al.
Udgivet: (2022-07-01)

In situ chemoimmunotherapy hydrogel elicits immunogenic cell death and evokes efficient antitumor immune response
af: Qin Liu, et al.
Udgivet: (2024-04-01)

Comparison of Immunotherapy, Chemotherapy, and Chemoimmunotherapy in Advanced Pulmonary Lymphoepithelioma-Like Carcinoma： A Retrospective Study
af: Yi Xiao, et al.
Udgivet: (2022-02-01)

Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma
af: Xin Wang, et al.
Udgivet: (2020-10-01)

Assessment of durable chemoimmunotherapy response via circulating tumor DNA in advanced esophageal squamous cell carcinoma
af: Dongyang Yang, et al.
Udgivet: (2022-10-01)

Spatial structure impacts adaptive therapy by shaping intra-tumoral competition
af: Strobl, MAR, et al.
Udgivet: (2022)

Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer
af: Udo S Gaipl, et al.
Udgivet: (2022-01-01)

Ferritin‐Based Nanocomposite Hydrogel Promotes Tumor Penetration and Enhances Cancer Chemoimmunotherapy
af: Rong Liu, et al.
Udgivet: (2024-01-01)

Activation of autophagy by in situ Zn2+ chelation reaction for enhanced tumor chemoimmunotherapy
af: Yang Yang, et al.
Udgivet: (2023-11-01)

Eradication of Established Murine Skin Tumors by Cyclic Chemoimmunotherapy with Cyclophosphamide and Effector T Cells
af: Koh Nakata, et al.
Udgivet: (2011-01-01)

Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
af: Seung Mo Jin, et al.
Udgivet: (2021-10-01)

Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations
af: Charlotte R. Bell, et al.
Udgivet: (2022-04-01)

182 Peripheral immunological features as predictors of breast cancer chemoimmunotherapy response
af: Justin M Balko, et al.
Udgivet: (2023-11-01)

Letter: Chemoimmunotherapy of adult acute leukaemia.
af: Peto, R, et al.
Udgivet: (1975)

Application of Neoadjuvant Chemoimmunotherapy in Resectable NSCLC
af: Huaiyong WANG, et al.
Udgivet: (2023-11-01)

MAPK signaling regulates the efficacy of chemoimmunotherapy
af: François Ghiringhelli
Udgivet: (2022-12-01)

Tumor-immune metaphenotypes orchestrate an evolutionary bottleneck that promotes metabolic transformation
af: West, J, et al.
Udgivet: (2024)

Safety and Efficacy of Neoadjuvant Chemoimmunotherapy versus Chemotherapy for Non-Small Cell Lung Cancer Undergoing Sleeve Resection
af: Qiu Y, et al.
Udgivet: (2024-09-01)

Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib
af: Baustin M. Welch, et al.
Udgivet: (2023-12-01)

Spatial structure impacts adaptive therapy by shaping intra-tumoral competition
af: Maximilian A. R. Strobl, et al.
Udgivet: (2022-04-01)

Tumor-immune metaphenotypes orchestrate an evolutionary bottleneck that promotes metabolic transformation
af: Jeffrey West, et al.
Udgivet: (2024-02-01)

Adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model
af: Hossein Naderi, et al.
Udgivet: (2021-01-01)

Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment
af: Lang X, et al.
Udgivet: (2024-05-01)

THE CHEMOIMMUNOTHERAPY BASED ON DENDRITIC CELLS AND CISPLATIN IN EXPERIMENT
af: Gorbach O. I., et al.
Udgivet: (2014-08-01)

Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study
af: Yuchen Wang, et al.
Udgivet: (2025-01-01)

Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study
af: Tianxiang Chen, MD, PhD, et al.
Udgivet: (2023-04-01)

A real‐world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non‐small cell lung cancer
af: Baihua Zhang, et al.
Udgivet: (2023-01-01)